To Amend Section 503 (b) of the Federal Food, Drug and Cosmetic Act of 1938, as Amended.Hearings, Eighty-second Congress, First Session, on S. 1186 and H.R. 3298. September 11, 12, and 13, 1951 |
From inside the book
Results 1-5 of 74
Page 9
... legislation , the Massachusetts Medical Society , Boston , Mass . , letter dated Aug. 10 , 1951 . Hayden , Arthur H. , trustee of the New York Pharmaceutical Co. , Bedford , Mass . , letter dated Aug. 13 , 1951 . 287 288 287 Page Heine ...
... legislation , the Massachusetts Medical Society , Boston , Mass . , letter dated Aug. 10 , 1951 . Hayden , Arthur H. , trustee of the New York Pharmaceutical Co. , Bedford , Mass . , letter dated Aug. 13 , 1951 . 287 288 287 Page Heine ...
Page 10
... Legislation , Naper- ville , Ill . , letter dated July 18 , 1951- 292 Patterson , Warren D. , Sansby Drug Co. , St. Paul , Minn . , letter dated Aug. 27 , 1951__ 292 Pierce , R. Vaughn , president , Pierce's Proprietaries , Inc ...
... Legislation , Naper- ville , Ill . , letter dated July 18 , 1951- 292 Patterson , Warren D. , Sansby Drug Co. , St. Paul , Minn . , letter dated Aug. 27 , 1951__ 292 Pierce , R. Vaughn , president , Pierce's Proprietaries , Inc ...
Page 11
... legislation are well sum- marized on page 2 of Report No. 700 to accompany H. R. 3298 from the Committee on Interstate and Foreign Commerce of the House of Representatives . The bill reported was identical with S. 1186 . The report ...
... legislation are well sum- marized on page 2 of Report No. 700 to accompany H. R. 3298 from the Committee on Interstate and Foreign Commerce of the House of Representatives . The bill reported was identical with S. 1186 . The report ...
Page 11
... legislative day , June 27 , 1951 . It states : Amendments in the nature of a substitute . Senator NEELY . You are reading from the amended bill . I asked you about the original bill , S. 1186 , which was introduced on the 21st day of ...
... legislative day , June 27 , 1951 . It states : Amendments in the nature of a substitute . Senator NEELY . You are reading from the amended bill . I asked you about the original bill , S. 1186 , which was introduced on the 21st day of ...
Page 30
... legislation to deal with barbiturates . We were content to let that problem of the barbiturates be considered separately by itself and to let the Congress decide what particular safeguards they would want to apply , if any , to deal ...
... legislation to deal with barbiturates . We were content to let that problem of the barbiturates be considered separately by itself and to let the Congress decide what particular safeguards they would want to apply , if any , to deal ...
Other editions - View all
Common terms and phrases
Administrative Procedure Act agency amendment American Pharmaceutical April 24 Association of Retail attacks barbital barbiturates Benzedrine bill capsules CARROLL Congress contained correct Cosmetic Act counter counts court CREEVY CULLEN dangerous drugs dangerous to health determination Dexedrine dispensing doctor dosage Drug Administration Drug Manufacturers Drug Store DUNN effect efficacy epilepsy epileptic exemption fact Federal Food Federal Security Federal Security Agency filed Food and Drug guilty HARROP hearing hypothyroidism interest labeling LARRICK legislation Marmola medicines misbranded nolo contendere obesity objective definition opinion oral prescriptions over-the-counter packages patient Pharmaceutical Association pharmacist pharmacy phenobarbital physician Plea practice prescribed prescription drug prescription legend present law proposed Proprietary Association protection provisions public health question refill regulation retail druggist seconal section 502 Sekov Senator HUMPHREY Senator IVES Senator LEHMAN Senator NEELY sold statement tablets thyroid tion toxicity trading treatment United States attorney WALLER WARNACK Western Medical Corp
Popular passages
Page 77 - The study shall incorporate guidelines which are consistent with criteria provided in resolutions adopted by the Committee on Labor and Public Welfare of the United States Senate or the Committee on Education and Labor of the United States House of Representatives, or both.
Page 116 - ... generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures (or, in the case of a substance used in food prior to January 1, 1958.
Page 264 - Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users...
Page 268 - If it is dangerous to health when used in the dosage, or with the frequency or duration prescribed, recommended, or suggested in the labeling thereof.
Page 85 - ... (B) because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug...
Page 246 - ... representations made or suggested by statement, word, design, device, sound, or any combination thereof, but also the extent to which the advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the commodity to which the advertisement relates under the conditions prescribed in said advertisement, or under such conditions as are customary or usual.
Page 11 - ... by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist. The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale.
Page 150 - Nor does it mean that even as to matters not requiring expertise a court may displace the board's choice between two fairly conflicting views, even though the court would justifiably have made a different choice had the matter been before it de novo.
Page 151 - When an agency finds that justice so requires, it may postpone the effective date of action taken by it, pending judicial review. On such conditions as may be required and to the extent necessary to prevent irreparable injury...
Page 40 - The findings of fact by the Commissioner, unless substantially contrary to the weight of the evidence, shall be conclusive...